Ian Tattersall is a Dermatology physician affiliated with NYU Langone Health. OpenAlex indexes 67 publications with 3,177 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
240 E 38th St Fl 12
New York, NY 100162708
Telephone
212-263-5250Provider last certified this registry record 1 Jun 2021.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Cipher Pharmaceuticals US LLCProgram year20251 payment
- EMD Serono Research & Development Institute, Inc.Program year20242 payments
- PFIZER INC.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
33.3%Corticosteroid16.4%Triamcinolone Acetonide94%Halobetasol Propionate6%Part D<11 patientsInterleukin-4 Receptor alpha Antagonist11.6%Dupixent Pen100%Part D≥25 patients+ 3 more classes in this area
Anti-infectives
21.6%Azole Antifungal10.9%Ketoconazole100%Part D≥55 patientsLincosamide Antibacterial4.9%Clindamycin Phosphate100%Part D≥24 patients+ 3 more classes in this area
Sensory organs
18.8%Corticosteroid17.1%Hydrocortisone54%Clobetasol Propionate46%Part D≥67 patientsAminoglycoside Antibacterial1.7%Gentamicin Sulfate100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dermatology images: Clinical presentations of autoimmune bullous disorders in skin of color
Journal of the American Academy of Dermatology
2026 - Adverse effects of scalp cooling for the reduction of chemotherapy-induced alopecia: A systematic review and meta-analysis
Breast Cancer Research and Treatment
2025 - Low-Dose Oral Minoxidil during Chemotherapy: A Review of the Mechanism and Current Evidence
Skin Appendage Disorders
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Harvey Pass, MD
NYU Langone Health
Gareth Morgan, MD
NYU Langone Health
Douglas Kondziolka, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”